This article is based on a lecture presented at the Tripartite Meeting, EVF-AVF-UKVF, Royal Society of Medicine, London, 1 July 2006.
References
1.
EklofB., RutherfordR.B., BerganJ.J.. for the American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement.J Vasc Surg2004; 40: 1248–52
2.
BrowseN.L., BurnandK.G.The cause of venous ulceration.Lancet1982; 2: 243–5
3.
JoshiA., SloanP.Role of ‘fibrin’ cuffs in chronic nonspecific oral ulceration.Wound Repair and Regeneration2004; 12: 18
4.
ZamboniP., ScapoliG., LanzaraV.. Serum iron and MMP-9 variations in limbs affected by chronic venous disease and venous leg ulcers.Dermatol Surg2005; 31: 644–9
5.
ZamboniP., IzzoM., TognazzoS.. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis.Free Radic Biol Med2006; 40: 1869–73
6.
ZamboniP., TognazzoS., IzzoM.. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration.J Vasc Surg2005; 42: 309–14
7.
WenkJ., FoitzikA., AchterbergV.. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing.Concept J Invest Dermatol2001; 116: 833–9
8.
AckermanZ., SeidenbaumM., LoewenthalE., RubinowA.Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease.Arch Dermatol1988; 124: 1376–8
9.
ZamboniP., IzzoM., FogatoL., CarandinaS., LanzaraV.Urine haemosiderin: a novel marker to assess the severity of chronic venous disease.J Vasc Surg2003; 37: 132–6
10.
Coleridge SmithP.D., ThomasP., ScurrJ.H., DormandyJ.A.Causes of venous ulceration: a new hypothesis.BMJ1988; 296: 1726–7
WilkinsonL.S., BunkerC., EdwardsJ.C., ScurrJ.H., SmithP.D.Leukocytes: their role in the etiopathogenesis of skin damage in venous disease.J Vasc Surg1993; 17: 669–75
13.
Yeoh-EllertonS., StaceyM.C.Iron and 8-isoprostane levels in acute and chronic wounds.J Invest Dermatol2003; 121: 918–25
14.
SullivanJ.L.Is stored iron safe?J Lab Clin Med2004; 144: 280–4
15.
HerouyY., MelliosP., BanderirE.. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression.J Dermat Science2001; 25: 198–205
16.
GurjarM.V., DeleonJ., SharmaR.V., BhallaR.C.Role of reactive oxygen species in IL-1-stimulated sustained ERK activation and MMP-9 induction.Am J Phys2001; 281: H2568–H2574
17.
FogT.The topography of plaques in multiple sclerosis with special reference to cerebral plaques.Acta Neurol Scand1965; 15(Suppl): 1–161
18.
PutnamT.J.Lesions of ‘encephalomyelitis'and multiple sclerosis. Venous thrombosis as the primary alteration.JAMA1937; 108: 1477
19.
AllenI.V.The pathology of multiple sclerosis fact, fiction and hypothesis.Neuropathol Appl Neurobiol1981; 7: 169
20.
AdamsC.W.Vascular aspects of multiple sclerosis. In: A Colour Atlas of Multiple Sclerosis and Other Myelin Disorders.London: Wolfe Medical Publication, 1989: 184–187.
21.
AdamsC.W., PostonR.N., BukS.J.Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis.J Neurol Sci1989; 92: 291–306
22.
TanI.L., van SchijndelR.A., PouwelsP.J.. MR venography of multiple sclerosis.AJNR Am J Neuroradiol2000; 21: 1039–42
23.
HorowitzA.L., KaplanR.D., GreweG., WhiteR.T., SalbergL.M.The ovoid lesion: a new MR observation in patients with multiple sclerosis.AJNR Am J Neuroradiol1989; 10: 303–5
KermodeA.G., ThompsonA.J., ToftsP.. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.Brain1990; 113: 1477–89
26.
KuenzB., LutterottiA., KhalilM.. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.J Neuroimmunol2005; 167: 143–9
27.
MartinoG., AdoriniL., RieckmannP.. Inflammation in multiple sclerosis: the good, the bad, and the complex.Lancet Neurol2002; 1: 499–509
28.
HaackeE.M., ChengN.Y., HouseM.J.. Imaging iron stores in the brain using magnetic resonance imaging.Magn Reson Imaging2005; 23: 1–25
29.
RubioJ.P., BahloM., TubridyN.. Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis.Hum Genet2004; 114: 573–80
30.
FainardiE., CastellazziM., BelliniT.. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.Mult Scler2006; 12: 294–301
